Cargando…
Thioredoxin-1: A Promising Target for the Treatment of Allergic Diseases
Thioredoxin-1 (Trx1) is an important regulator of cellular redox homeostasis that comprises a redox-active dithiol. Trx1 is induced in response to various stress conditions, such as oxidative damage, infection or inflammation, metabolic dysfunction, irradiation, and chemical exposure. It has shown e...
Autores principales: | Wang, Jinquan, Zhou, Jiedong, Wang, Cuixue, Fukunaga, Atsushi, Li, Shujing, Yodoi, Junji, Tian, Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095844/ https://www.ncbi.nlm.nih.gov/pubmed/35572600 http://dx.doi.org/10.3389/fimmu.2022.883116 |
Ejemplares similares
-
Progress in the mechanism and targeted drug therapy for COPD
por: Wang, Cuixue, et al.
Publicado: (2020) -
Thioredoxin Ameliorates Cutaneous Inflammation by Regulating the Epithelial Production and Release of Pro-Inflammatory Cytokines
por: Tian, Hai, et al.
Publicado: (2013) -
Thioredoxin/Txnip: Redoxisome, as a Redox Switch for the Pathogenesis of Diseases
por: Yoshihara, Eiji, et al.
Publicado: (2014) -
Geranylgeranylacetone Ameliorates Skin Inflammation by Regulating and Inducing Thioredoxin via the Thioredoxin Redox System
por: Jin, Tiancheng, et al.
Publicado: (2023) -
Anti-Inflammatory Thioredoxin Family Proteins for Medicare, Healthcare and Aging Care
por: Yodoi, Junji, et al.
Publicado: (2017)